Merrill Chase Inadvertently Disproved Antibodies in 1942

Written by Mike Stone on July 11, 2024. Posted in Current News

When I first began uncovering the fraud of virology, I was still somehow convinced that there was such a thing as an “immune system” that utilized substances called “antibodies” in order to protect us from outside pathogens

While I understood that vaccination was dangerous due to the toxic recipes used in their creation, my counter to those pushing for vaccine-acquired “immunity” was to argue in support of naturally acquired “herd-immunity.”

I was stuck in this false-binary paradigm as I was still working through the unscientific methodologies used by virologists to claim that invisible pathogenic “viruses” existed.

I also had not let go of the idea that bacteria and fungi were invading pathogens as I had not expanded the scope of my inquiries to go beyond “viruses” at that time, and I had yet to truly understand the terrain theory.

It wasn’t until I fully understood the importance of purification and isolation procedures for establishing a valid independent variable when using biological materials, as well as the lack of adherence to the scientific method in the virology literature, that I began to question “antibodies” and the entire concept of “immunity” as they are so closely intertwined.

For anyone unfamiliar, purification means that a substance is free of any contaminants, pollutants, foreign materials, etc. that debase it, whereas isolation refers to the complete separation of one thing from everything else.

In regard to virology, this should mean that the “viral” particles are separated entirely in a single form away from any host and foreign materials, cell debris, contaminants, etc. However, the meanings for both purification and isolation have been debased in virology and do not represent the common understanding of the words.

One of the common excuses used by researchers for the inability to completely purify and isolate “viruses” prior to any experiments taking place is that they are too small, and therefore, the “viral” particles will collect and co-sediment with any similar particles that are of the same size and density.

It is admitted by researchers that the technology needed to completely separate the assumed “viral” particles even from extracellular vesicles such as “exosomes” that are of the same size and density, does not exist.

Thus, complete purification and isolation is unable to be achieved in order to have a valid independent variable for study.

Since typical “viruses” range from 20 to 300 nanometers (nm) in diameter and “antibodies” are said to be much smaller, around 10 nm, it became clear to me that if researchers cannot purify and isolate “viruses” directly from a sick host in order to manipulate them in experiments, they would also be unable to do this for the even smaller “antibody” particles.

This line of inquiry led me to examine the pivotal moments in the history of “antibody” research, beginning with papers written in 1890, in order to uncover how these entities were discovered and how they had their functioning determined.

Upon doing so, I came to the realization that the same problems affecting “viruses” applied to “antibodies,” specifically in regard to the inability to purify and isolate the assumed “antibodies” in order to have them on hand to vary and manipulate during experimentation.

Like “viruses,” the “antibody” was a hypothetical entity that was created to explain unnatural reactions observed when mixing blood from different species with various chemicals in Petri dishes.

These particles were purely (pun somewhat intended) an imaginary concept, and were unable to be directly observed. I found out that there were no less than six different theories proposed over the course of decades trying to describe how these invisible particles form and function due to the inability to actually witness the processes that they were claimed to be involved in.

On top of these problems, I also became aware of the issues with the lack of specificity of the hypothetical “antibodies” to react and bind only to their intended target.

This caused many problems for the research papers written using these entities, resulting in a reproducibility crisis where researchers have been unable to reproduce and replicate their own findings as well as those of their peers due to the inconsistent reactions observed within the lab.

It was a long rabbit hole to go through, and there are still a few articles in need of being updated for the ViroLIEgy.com site. When it is all completed, I plan to do a summarized write-up of the timeline and findings in the future.

However, until then, here are the articles in a mostly chronological order based upon the date of the “discoveries.”

1. Emil Von Behring’s Diphtheria/Tetanus Papers (1890): Precursor to Antibodies
2. Paul Ehrlich’s Side-Chain Antibody Theory (1900) Part 1
3. Paul Ehrlich’s Side-Chain Antibody Theory (1900) Part 2: The Complement System
4. The Antibody Equation (1929)
5. Direct Template and the Theoretical Structure of Antibodies (1930-1940)
6. Antibodies, Plasma, and the Power of Correlation
7. The Indirect Template Theory of Antibody Production (1949)
8. The Natural Selection Theory of Antibody Formation (1955)
9. The Clonal Selection Antibody Theory (1957)
10. Was the First Atomic Resolution Structure of an Antibody Fragment Published in 1973?
11. The Chemical Structure of Antibodies?

In order to complete this investigation into “antibodies,” I have updated one of the last articles that I had written as a part of this effort, originally posted to Facebook back on May 4th, 2021.

The research covered in this article took place in 1942 and 1947. Thus, it is a little out of order in the chronological timeline.

However, the findings were not deemed significant until later, and I had initially stumbled upon it at the end of my investigation.

The rest of this article is behind a paywall. See it here substack.com

Please Donate Below To Support Our Ongoing Work To Defend The Scientific Method

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Trackback from your site.